Poster Abstract Session:
219. Antimicrobial Stewardship: New Methods and Metrics
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Investigative ID, Adult ID


Presentations:
Development and validation of novel ambulatory antibiotic stewardship metrics
Keith W. Hamilton, MD; Kathleen O. Degnan, MD; Valerie Cluzet, MD; Leigh Cressman, MA; Afia B. Adu-Gyamfi, BA; Pam Tolomeo, MPH; Michael Z. David, MD, PhD
Posters
  • Outpatient Poster 2018 v2.pdf (312.4 kB)
  • External Validation of Precision Antibiotic Therapy for Enterococcal Bloodstream Infections
    Tiffany Lee, PharmD; Melissa White, PharmD; Shannon Overly, MS; Jimish Mehta, PharmD, MSCE; Shawn Binkley, BS, PharmD; Steven Morgan, PharmD, BCPS, AQID; Stephen Saw, PharmD; Keith Hamilton, MD
    Effects of syndrome-based antimicrobial stewardship prospective audit and feedback interventions on antimicrobial use in an urban community hospital
    Alfredo J. Mena Lora, MD; Martin Cortez, PharmD; Rick Chu, PharmD; Ella Li, PharmD; Scott Borgetti, MD; Yolanda Coleman, PhD, RN; Sherrie Spencer, RN, MSN; Candice Krill, BSN, MBA; Eden Takhsh, MD; Susan C. Bleasdale, MD
    Posters
  • SAH ASP.pdf (921.6 kB)
  • Benchmarking Outpatient Antimicrobial Use in Manitoba through Population Based Research
    Sergio Fanella, MD, FRCPC; Rupeena Purewal, MD; Roxanna Dragan, MA; Heather J Prior, MSc; Dale Stevenson, MA; Jeff Valdivia, MNRM; Chelsea Ruth, MD, FRCPC
    Characteristics of a Cohort of Patients on Broad-Spectrum Antibiotics Targeted for Prospective Audit and Feedback.”
    Rachel Bystritsky, MD; Albert T Young, BA; Andrew Wong, BA; Alexandra Hilts-Horeczko, PharmD; Conan Macdougall, PharmD, MAS, BCPS; Henry F. Chambers, MD; Sarah B. Doernberg, MD
    Antibiotic Prescribing Feedback: Description of Denominator Metrics to Standardize Prescribing Rates for Peer Comparison
    Travis Jones, PharmD; Melissa Johnson, PharmD, MHS; Rebekah W. Moehring, MD, MPH; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS
    Indirect Standardization: A Convenient Benchmarking Approach to Antibiotic Utilization Based on Patient Mix
    Andras Farkas, Pharm.D.; Kimberly Sarosky, PharmD; Joseph Sassine, MD; Arsheena Yassin, PharmD
    Posters
  • IDSA.2018 benchmark 9.28.pdf (985.8 kB)
  • Understanding the components and calculation of the SAAR, Illustrative Data
    Sean Avedissian, Pharm.D.; Nathaniel Rhodes, PharmD, MSc; Jiajun Liu, PharmD; Doaa Aljefri, PharmD, MSc; Michael Postelnick, RPh BCPS AQ ID; Sarah Sutton, MD; Teresa Zembower, MD, MPH, FIDSA; David Martin, PharmD; Gwendolyn Pais, PhD; Caroline Cruce, PharmD; Marc H. Scheetz, PharmD, MSc, BCPS AQ-ID
    Veterans are Special: Clinical Decision Tree Misses ESBL Status in Bacteremic Veterans
    Andrew Chou, MD; Richard Sucgang, PhD; Lynn Zechiedrich, PhD; Barbara W. Trautner, MD, PhD, FIDSA
    Signal or Noise? A comparison of methods to identify outliers in antimicrobial use (AU)
    Rebekah W. Moehring, MD, MPH; Eric Lofgren, MSPH, PhD; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Yuliya Lokhnygina, MS, PhD
    Posters
  • IDWeekPoster2018.pdf (441.0 kB)
  • Electronic measure of unnecessary antimicrobial use in US Veterans Affairs Medical Centers
    Makoto Jones, MD, MS; Vanessa Stevens, PhD; Barbara Jones, MD; Julia Lewis, DO; Kelly Peterson, MS; Karl Madaras-Kelly, PharmD, MPH; Christopher Graber, MD, MPH, FIDSA; Matthew Goetz, MD, FIDSA, FSHEA; Peter Glassman, MBBS, MSc

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.